Quantitation of the five forms of plasma high molecular weight angiotensinogen in women with pregnancy-induced hypertension

American Journal of Hypertension

Volumn 13, Issue 3, 2000, Pages 221-225

  Tewksbury, Duane A ^a,b   Goodman, Jean R ^a,b   Kaiser, Steven J ^a,b   Burrill, Raymond E ^a,b   Brown, Haywood L ^a,b  

^a MARSHFIELD CLINIC   (United States)

^b ST VINCENT HOSPITAL   (United States)

Author keywords

High molecular weight angiotensinogen; Low molecular weight angiotensinogen; Pregnancy induced hypertension

Indexed keywords

ANGIOTENSINOGEN;

ARTICLE; BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; ISOMER; MATERNAL HYPERTENSION; MOLECULAR WEIGHT; NEGRO; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANGIOTENSINOGEN; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MOLECULAR WEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTEIN ISOFORMS;

EID: 0034112580     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00191-0     Document Type: Article

References (13)

1. Tewksbury D.A., Dart R.A. High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension. 4:1982;729-734.
2. Tryon E.S., Tewksbury D.A. Kinetic analysis of the reaction of human renin with human high and low molecular weight angiotensinogen. Hypertens Preg. 14:1995;327-338.
3. Tewksbury D.A., Tryon E.S., Burrill R.E., Dart R.A. High molecular weight angiotensinogen a pregnancy associated protein . Clin Chim Acta. 158:1986;7-12.
4. Lenz T., Sealey J.E., Tewksbury D.A. Regional distribution of the angiotensinogens in human placentae. Placenta. 14:1993;695-699.
5. Tewksbury D.A. Quantitation of five forms of high molecular weight angiotensinogen from human placenta. Am J Hypertens. 9:1996;1029-1034.
6. Bloem L.J., Manatunga A.K., Tewksbury D.A., Pratt J.H. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 95:1995;948-953.
7. Tewksbury D, Frome W, Kaiser S, Vevea D: Study of the composition and formation of high molecular weight angiotensinogen. Hypertension 1997;29:847.
8. Stein P.E., Tewksbury D.A., Carrell R.W. Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem J. 262:1989;103-107.
9. Carrell R.W., Stein P.E. The biostructural pathology of the serpins critical function of sheet opening mechanism . Biol Chem Hoppe-Seyler. 377:1996;1-17.
10. Patston P.A., Hauert J., Michaud M., Schapira M. Formation and properties of C1-inhibitor polymers. FEBS Lett. 368:1995;401-404.
11. Stein P.E., Carrell R.W. What do dysfunctional serpins tell us about molecular mobility and disease? Structural Biol. 2:1995;96-113.
12. Mikus P., Ny T. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J Biol Chem. 271:1996;10048-10053.
13. Paul M., Wagner J., Dzau V.J. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest. 91:1993;2058-2064.